Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study

被引：0
|
作者：
Chao Xu
Xiaoli Xie
Ning Kang
Huiqing Jiang
机构：
[1] The Second Hospital of Hebei Medical University,Department of Gastroenterology
[2] Handan Central Hospital,Department of Gastroenterology
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Locally advanced gastric cancer; Apatinib; Programmed cell death protein 1 inhibitor; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4091 / 4099
页数：8
相关论文
共 50 条
  • [21] The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
    Chenghai Zhang
    Binghong Wu
    Hong Yang
    Zhendan Yao
    Nan Zhang
    Fei Tan
    Maoxing Liu
    Kai Xu
    Lei Chen
    Jiadi Xing
    Ming Cui
    Xiangqian Su
    BMC Cancer, 22
  • [22] Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
    Zhang, Yonglei
    Zhang, Bin
    Yang, Jinpo
    Zhang, Jindai
    Zhang, Wei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2279 - 2286
  • [23] PD-1 inhibitor plus concurrent chemoradiotherapy for high-risk locally advanced cervical cancer
    Wang, Cong
    Liu, Lijun
    Li, Xia
    Lei, Jia
    Li, Yiqian
    Shen, Zhibo
    Shi, Huirong
    Cheng, Yan
    FUTURE ONCOLOGY, 2024, 20 (20) : 1415 - 1426
  • [24] Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study
    Li, Li-Hua
    Chen, Wen-Chao
    Wu, Gang
    DISEASE MARKERS, 2022, 2022
  • [25] Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
    Cui, Qingli
    Mao, Yuefeng
    Wu, Daoyuan
    Hu, Yanhui
    Ma, Dongyang
    Zhang, LiHan
    Liu, Huaimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients
    Pan, Dengdeng
    Liu, Dongliang
    Liang, Lichuan
    Shen, Tongyi
    Shi, Chenzhang
    Qin, Huanlong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Efficacy and prognosis analyses of apatinib combined with S-1 in third-line chemotherapy for advanced gastric cancer
    Wu, Qiuju
    Fu, Yingchun
    Wen, Wenlong
    Xi, Ting
    Zhao, Guangling
    JOURNAL OF BUON, 2020, 25 (02): : 987 - 994
  • [28] The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
    Xinxin Wang
    Shuo Li
    Yihong Sun
    Kai Li
    Xian Shen
    Yingwei Xue
    Pin Liang
    Guoli Li
    Luchuan Chen
    Qun Zhao
    Guoxin Li
    Weihua Fu
    Han Liang
    Hairong Xin
    Jian Suo
    Xuedong Fang
    Zhichao Zheng
    Zekuan Xu
    Huanqiu Chen
    Yanbing Zhou
    Yulong He
    Hua Huang
    Linghua Zhu
    Kun Yang
    Jiafu Ji
    Yingjiang Ye
    Zhongtao Zhang
    Fei Li
    Xin Wang
    Yantao Tian
    Sungsoo Park
    Lin Chen
    BMC Cancer, 21
  • [29] The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
    Wang, Xinxin
    Li, Shuo
    Sun, Yihong
    Li, Kai
    Shen, Xian
    Xue, Yingwei
    Liang, Pin
    Li, Guoli
    Chen, Luchuan
    Zhao, Qun
    Li, Guoxin
    Fu, Weihua
    Liang, Han
    Xin, Hairong
    Suo, Jian
    Fang, Xuedong
    Zheng, Zhichao
    Xu, Zekuan
    Chen, Huanqiu
    Zhou, Yanbing
    He, Yulong
    Huang, Hua
    Zhu, Linghua
    Yang, Kun
    Ji, Jiafu
    Ye, Yingjiang
    Zhang, Zhongtao
    Li, Fei
    Wang, Xin
    Tian, Yantao
    Park, Sungsoo
    Chen, Lin
    BMC CANCER, 2021, 21 (01)
  • [30] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Sasaki, Kinro
    Onodera, Shinichi
    Otsuka, Kichiro
    Satomura, Hitoshi
    Kurayama, Eigo
    Kubo, Tsukasa
    Takahashi, Masakazu
    Ito, Jun
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Miyachi, Kazuhito
    Kato, Hiroyuki
    MEDICAL ONCOLOGY, 2017, 34 (08)
12345